For the month ended 31 May 2026, China Health Group Limited maintained a stable equity position, recording no movements in either authorised or issued share capital.

Authorised Capital • Ordinary shares: 100 billion shares at HKD 0.10 par value, representing authorised capital of HKD 10.00 billion; unchanged from the previous month. • Redeemable Convertible Cumulative Preference shares: 15,000 shares at USD 0.01 par value (equivalent to HKD 1,164); no change.

Issued Shares and Public Float • Issued ordinary shares stood at 1.39 billion, with zero treasury shares outstanding. • There were no share issuances, buy-backs or cancellations during the month, keeping total issued shares unchanged at 1.39 billion. • The company confirmed compliance with the minimum 25 percent public-float requirement under Main Board Rule 13.32B.

Equity Incentives • Share Option Scheme: 20.84 million options remained outstanding, with no exercises and no new grants. • Warrants, convertibles or other share-based agreements: none reported. • Total funds raised from option exercises in May: HKD 0.

Overall, China Health’s monthly return indicates an unchanged capital base, full adherence to Hong Kong listing requirements, and a consistent public float level.